Limited Efficacy Against Omicron Note: The following item was provided by the Georgia Department of Public Health for posting. -KtE Atlanta – The U.S. Food and Drug Administration (FDA) has announced that two monoclonal antibody (mAb) treatments for COVID-19 are currently not authorized for use due to their limited effectiveness against the Omicron variant. Omicron is […]